Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited range of anticancer drugs, radiotherapy, and photodynamic therapy, represents a recent innovation in the revitalized and burgeoning field of oncoimmunnotherapy. ICD results in the cellular redistribution and ext...

Full description

Bibliographic Details
Main Authors: Bernardo L. Rapoport, Ronald Anderson
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:International Journal of Molecular Sciences
Subjects:
calreticulin
damage-associated molecular patterns (DAMPs)
dendritic cells
high mobility group box1
immunogenic cell death
immune checkpoint inhibitors
monoclonal antibodies
type I interferons
Online Access:https://www.mdpi.com/1422-0067/20/4/959

Internet

https://www.mdpi.com/1422-0067/20/4/959

Similar Items